BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36224555)

  • 1. A bayesian approach to model the underlying predictors of early recurrence and postoperative death in patients with colorectal Cancer.
    Mahmoudi L; Fallah R; Roshanaei G; Asghari-Jafarabadi M
    BMC Med Res Methodol; 2022 Oct; 22(1):269. PubMed ID: 36224555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the impact of stage and tumor site on colorectal cancer survival: Bayesian survival modeling.
    Alinia S; Ahmadi S; Mohammadi Z; Rastkar Shirvandeh F; Asghari-Jafarabadi M; Mahmoudi L; Safari M; Roshanaei G
    Sci Rep; 2024 Feb; 14(1):4270. PubMed ID: 38383712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence and Postoperative Death in Patients with Colorectal Cancer: A New Perspective via Semi-competing Risk Framework.
    Safari M; Mahmoudi L; Baker EK; Roshanaei G; Fallah R; Shahnavaz A; Asghari-Jafarabadi M
    Turk J Gastroenterol; 2023 Jul; 34(7):736-746. PubMed ID: 37232463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.
    Zhang Y; Chen MH; Ibrahim JG; Zeng D; Chen Q; Pan Z; Xue X
    Lifetime Data Anal; 2014 Jan; 20(1):76-105. PubMed ID: 23543121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific causes of recurrence after surgery and mortality in patients with colorectal cancer: A competing risks survival analysis.
    Safari M; Mahjub H; Esmaeili H; Abbasi M; Roshanaei G
    J Res Med Sci; 2021; 26():13. PubMed ID: 34084192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint modelling of colorectal cancer recurrence and death after resection using multi-state model with cured fraction.
    Alafchi B; Roshanaei G; Tapak L; Abbasi M; Mahjub H
    Sci Rep; 2021 Jan; 11(1):1016. PubMed ID: 33441746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian inference of the fully specified subdistribution model for survival data with competing risks.
    Ge M; Chen MH
    Lifetime Data Anal; 2012 Jul; 18(3):339-63. PubMed ID: 22484596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A competing risk analysis of colorectal cancer recurrence after curative surgery.
    Schellenberg AE; Moravan V; Christian F
    BMC Gastroenterol; 2022 Mar; 22(1):95. PubMed ID: 35241002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC.
    Li J; Li X; Gu J; Ma X; Xue F
    Jpn J Clin Oncol; 2018 Dec; 48(12):1088-1095. PubMed ID: 30257010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer.
    Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
    Clin Transl Oncol; 2018 Feb; 20(2):176-192. PubMed ID: 28710725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.
    Wong CK; Law WL; Wan YF; Poon JT; Lam CL
    BMC Cancer; 2014 May; 14():337. PubMed ID: 24886385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort study.
    Castells A; Bessa X; Daniels M; Ascaso C; Lacy AM; García-Valdecasas JC; Gargallo L; Novell F; Astudillo E; Filella X; Piqué JM
    Dis Colon Rectum; 1998 Jun; 41(6):714-23; discussion 723-4. PubMed ID: 9645739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the survival of patients with colorectal cancer using random survival forest.
    Roshanaei G; Safari M; Faradmal J; Abbasi M; Khazaei S
    J Gastrointest Cancer; 2022 Mar; 53(1):64-71. PubMed ID: 33174117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer.
    Goh CH; Leong WQ; Chew MH; Pan YS; Tony LK; Chew L; Tan IB; Toh HC; Tang CL; Fu WP; Chia WK
    Anticancer Res; 2014 Dec; 34(12):7407-14. PubMed ID: 25503181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian Model Assessment for Jointly Modeling Multidimensional Response Data with Application to Computerized Testing.
    Liu F; Wang X; Hancock R; Chen MH
    Psychometrika; 2022 Dec; 87(4):1290-1317. PubMed ID: 35349031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.
    Kishiki T; Lapin B; Matsuoka H; Watanabe T; Takayasu K; Kojima K; Sugihara K; Masaki T
    Dis Colon Rectum; 2018 Jan; 61(1):51-57. PubMed ID: 29215480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?
    Nandra R; Parry M; Forsberg J; Grimer R
    Clin Orthop Relat Res; 2017 Jun; 475(6):1681-1689. PubMed ID: 28397168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major postoperative complications following elective resection for colorectal cancer decrease long-term survival but not the time to recurrence.
    Odermatt M; Miskovic D; Flashman K; Khan J; Senapati A; O'Leary D; Thompson M; Parvaiz A
    Colorectal Dis; 2015 Feb; 17(2):141-9. PubMed ID: 25156234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The survival prediction model of advanced gallbladder cancer based on Bayesian network: a multi-institutional study].
    Tang ZH; Geng ZM; Chen C; Si SB; Cai ZQ; Song TQ; Gong P; Jiang L; Qiu YH; He Y; Zhai WL; Li SP; Zhang YC; Yang Y
    Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):342-349. PubMed ID: 29779309
    [No Abstract]   [Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.